Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Altoida raises $6.3M Series A for AI Alzheimer's risk predictor - MassDevice
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Altoida Raises $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality | Venture Incubator
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Worldwebforum
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ο Έλληνας ερευνητής Ιωάννης Ταρνανάς κατέκτησε το κορυφαίο ευρωπαϊκό βραβείο καινοτομίας! Προβλέπει το Αλτσχάιμερ στα 6 χρόνια (Φωτό & Βίντεο) | eirinika.gr
Ο Έλληνας ερευνητής Ιωάννης Ταρνανάς κατέκτησε το κορυφαίο ευρωπαϊκό βραβείο καινοτομίας! Προβλέπει το Αλτσχάιμερ στα 6 χρόνια (Φωτό & Βίντεο) | eirinika.gr
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas - Worldwebforum
Tweets with replies by Altoida, Inc. (@altoida) / Twitter
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Altoida's Alzheimer's-predicting smartphone app snags FDA breakthrough status | Fierce Biotech
Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson's Disease Diagnosis | Business Wire
Altoida Receives Investment from Alzheimer's Drug Discovery Foundation
Altoida, Inc. (@altoida) / Twitter
